A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF)

NCT06122831 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

92

Enrollment

INDUSTRY

Sponsor class

Conditions

Myelofibrosis

Interventions

DRUG: TQ05105 Tablets
DRUG: TQB3617 Capsules

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.